U7 snRNA acts as a transcriptional regulator interacting with an inverted CCAAT sequence-binding transcription factor NF-Y

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 2, 2008, Pages 274-281

  Higuchi, Takashi ^a   Anzai, Kaijiro ^a   Kobayashi, Shunsuke ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Inverted CCAAT sequence; NF Y; Transcriptional regulator; U7 snRNA

Indexed keywords

CCAAT BINDING FACTOR; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN 1; NUCLEAR FACTOR Y; PROTEIN P53; RIBONUCLEASE A; SMALL NUCLEAR RNA; SMALL NUCLEAR RNA U7; UNCLASSIFIED DRUG; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENE SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA BINDING; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CCAAT-BINDING FACTOR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; PROMOTER REGIONS (GENETICS); RNA, SMALL NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 38549160579     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.11.005     Document Type: Article

References (38)

1. Labialle S., Gayet L., Marthinet E., Rigal D., and Baggetto L.G. Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem. Pharmacol. 64 (2002) 943-948
2. Bargou R.C., Jurchott K., Wagener C., Bergmann S., Metzner S., Bommert K., Mapara M.Y., Winzer K.J., Dietel M., Dorken B., Dorken B., and Royer H.D. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat. Med. 3 (1997) 447-450
3. Ohga T., Uchiumi T., Makino Y., Koike K., Wada M., Kuwano M., and Kohno K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273 (1998) 5997-6000
4. Janz M., Harbeck N., Dettmar P., Berger U., Schmidt A., Jurchott K., Schmitt M., and Royer H.D. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int. J. Cancer 97 (2002) 278-282
5. Basaki Y., Hosoi F., Oda Y., Fotovati A., Maruyama Y., Oie S., Ono M., Izumi H., Kohno K., Sasaki K., Shimoyama T., Nishino K., and Kuwano M. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene 26 (2007) 2736-2746
6. Sundseth R., MacDonald G., Ting J., and King A.C. DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter. Mol. Pharmacol. 51 (1997) 963-971
7. Hu Z., Jin S., and Scotto K.W. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J. Biol. Chem. 275 (2000) 2979-2985
8. Okamura H., Yoshida K., Sasaki E., Morimoto H., and Haneji T. Transcription factor NF-Y regulates mdr1 expression through binding to inverted CCAAT sequence in drug-resistant human squamous carcinoma cells. Int. J. Oncol. 25 (2004) 1031-1037
9. Kaszubiak A., Kupstat A., Muller U., Hausmann R., Holm P.S., and Lage H. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Biochem. Biophys. Res. Commun. 357 (2007) 295-301
10. Matsumoto K., and Wolffe A.P. Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol. 8 (1998) 318-323
11. Cotton M., Gick O., Vasserot A., Schaffner G., and Birnstiel M.L. Specific contacts between mammalian U7 snRNA and histone precursor RNA are indispensable for the in vitro 3′ RNA processing reaction. EMBO J. 7 (1988) 801-808
12. Hamprecht B. Structural, electrophysiological, biochemical and pharmacological properties of neuroblastoma × glioma hybrids in cell culture. Int. Rev. Cytol. 49 (1977) 99-170
13. Furukawa M., Uchiumi T., Nomoto M., Takano H., Morimoto R.I., Naito S., Kuwano M., and Kohno K. The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase II alpha gene by heat shock. J. Biol. Chem. 273 (1998) 10550-10555
14. Funakoshi T., Kobayashi S., Ohashi S., Sato T.A., and Anzai K. Isolation and characterization of brain Y-box protein: developmentally regulated expression, polyribosomal association and dendritic localization. Brain Res. Mol. Brain Res. 118 (2003) 1-9
15. Kobayashi S., Kamo S., Ohmae A., Agui K., Li Y., and Anzai K. Identification of a negative regulatory DNA element for neuronal BC1 RNA expression by RNA polymerase III. Biochim. Biophys. Acta 1493 (2000) 142-150
16. Chomezynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
17. Phillips S.C., and Turner P.C. A transcriptional analysis of the gene encoding mouse U7 small nuclear RNA. Gene 116 (1992) 181-186
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
19. Maity S.N., Sinha S., Ruteshouser E.C., and de Crombrugghe B. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J. Biol. Chem. 267 (1992) 16574-16580
20. Harker W.G., Slade D.L., Parr R.L., Feldhoff P.W., Sullivan D.M., and Holguin M.H. Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res. 35 (1995) 1707-1716
21. Swamynathan S.K., Nambiar A., and Guntaka R.V. Role of single-stranded DNA regions and Y-box proteins in transcriptional regulation of viral and cellular genes. FASEB J. 12 (1998) 515-522
22. Skabkin M.A., Kiselyova O.I., Chernov K.G., Sorokin A.V., Dubrovin E.V., Yaminsky I.V., Vasiliev V.D., and Ovchinnikov L.P. Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res. 32 (2004) 5621-5635
23. Minich W.B., Maidebura I.P., and Ovchinnikov L.P. Purification and characterization of the major 50-kDa repressor protein from cytoplasmic mRNP of rabbit reticulocytes. Eur. J. Biochem. 212 (1993) 633-638
24. Soldati D., and Schumperli D. Structural and functional characterization of mouse U7 small nuclear RNA active in 3′ processing of histone pre-mRNA. Mol. Cell. Biol. 8 (1988) 1518-1524
25. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415
26. Wang H., Jiang Z., Wong Y.W., Dalton W.S., Futscher B.W., and Chan V.T. Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIalpha in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226. Biochem. Biophys. Res. Commun. 237 (1997) 217-224
27. Zhou Y., Mehta K.R., Choi A.P., Scolavino S., and Zhang X. DNA damage-induced inhibition of securin expression is mediated by p53. J. Biol. Chem. 278 (2003) 462-470
28. Joshi A.A., Wu Z., Reed R.F., and Suttle D.P. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs. Mol. Pharmacol. 63 (2003) 359-367
29. Southgate C., and Busslinger M. In vivo and in vitro expression of U7 snRNA genes: cis- and trans-acting elements required for RNA polymerase II-directed transcription. EMBO J. 8 (1989) 539-549
30. Evdokimova V., Ovchinnikov L.P., and Sorensen P.H. Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells. Biochemistry (Mosc) 71 (2006) 146-154
31. Jin S., Gorfajn B., Faircloth G., and Scotto K.W. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6775-6779
32. Tanaka H., Ohshima N., Ikenoya M., Komori K., Katoh F., and Hidaka H. HMN-176, an active metabolite of the synthetic antitumor agent HMN-214, restores chemosensitivity to multidrug-resistant cells by targeting the transcription factor NF-Y. Cancer Res. 63 (2003) 6942-6947
33. Fan X., Shi H., Adelman K., and Lis J.T. Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6934-6939
34. Zhao X., Shi H., Sevilimedu A., Liachko N., Nelson H.C., and Lis J.T. An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucleic Acids Res. 34 (2006) 3755-3761
35. Byers S.A., Price J.P., Cooper J.J., Li Q., and Price D.H. HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK. J. Biol. Chem. 280 (2005) 16360-16367
36. Kwek K.Y., Murphy S., Furger A., Thomas B., O'Gorman W., Kimura H., Proudfoot N.J., and Akoulitchev A. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat. Struct. Mol. Biol. 9 (2002) 800-805
37. Allen T.A., Von Kaenel S., Goodrich J.A., and Kugel J.F. The SINE-encoded mouse B2 RNA represses mRNA transcription in response to heat shock. Nat. Struct. Mol. Biol. 11 (2004) 816-821
38. Espinoza C.A., Allen T.A., Hieb A.R., Kugel J.F., and Goodrich J.A. B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat. Struct. Mol. Biol. 11 (2004) 822-829